Product Information
HALOPERIDOL LAC 5 MG/ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.7820 per ML under NDC 63323047401. Its NADAC has been published 303 times since Mar 23, 2016.
FDA first approved this application on Mar 9, 2001. Its Orange Book therapeutic-equivalence code is AP.
Strength
5 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323047401
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
HALOPERIDOL LACTATEApproval Type
Generic (ANDA)
FDA Application
ANDA075689FDA Approved
3/9/2001
TE Code
AP
On Market Since
10/20/2000
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL LAC 5 MG/ML VIAL has been published 303 times since Mar 23, 2016, and over the history we have for it it has declined 28.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7820 per ML |
|---|---|
| All-time high | $3.0333 (Aug 10, 2016) |
| All-time low | $0.7370 (Jun 18, 2025) |
| 52-week high | $0.7891 |
| 52-week low | $0.7653 |
| Median price | $0.7944 |
| Average price | $0.8705 |
| Largest weekly change | +177.1% (Jun 22, 2016) |
| Weeks tracked | 303 |
| Tracking since | Mar 23, 2016 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
HALOPERIDOL LACTATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL LAC 5 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL LAC 5 MG/ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $0.7820 per ML (NDC 63323047401), effective Sep 30, 2026.
How has the price of HALOPERIDOL LAC 5 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL LAC 5 MG/ML VIAL has declined 28.6%. It has been tracked across 303 weekly CMS publications since Mar 23, 2016.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL LAC 5 MG/ML VIAL?
Since Mar 23, 2016, the NADAC for HALOPERIDOL LAC 5 MG/ML VIAL has ranged from a low of $0.7370 (Jun 18, 2025) to a high of $3.0333 (Aug 10, 2016), with a median of $0.7944 per ML.
Are there cheaper alternatives to HALOPERIDOL LAC 5 MG/ML VIAL?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HALOPERIDOL LAC 5 MG/ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures HALOPERIDOL LAC 5 MG/ML VIAL?
HALOPERIDOL LAC 5 MG/ML VIAL (NDC 63323047401) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.